REVIVA PHARMACEUTICALS HOLDINGS, INC. short interest in 2023
In 2023, REVIVA PHARMACEUTICALS HOLDINGS, INC.'s disclosed short interest ran from 4.59% of shares outstanding on 13 Jan 2023 to 4.09% on 29 Dec 2023, a change of -0.50 percentage points. The year's high was 14.62% on 15 Nov 2023 and its low 3.83% on 15 Feb 2023, averaging 6.39% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.42 days on 14 Apr 2023. Full history: REVIVA PHARMACEUTICALS HOLDINGS, INC..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 4.59% (13 Jan 2023)
- End of year
- 4.09% (29 Dec 2023)
- Change
- -0.50 pp
- High
- 14.62% (15 Nov 2023)
- Low
- 3.83% (15 Feb 2023)
- Average
- 6.39%
- Highest days to cover
- 19.42 (14 Apr 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 4.59% | 5.37 | |
| 31 Jan 2023 | 4.05% | 8.25 | |
| 15 Feb 2023 | 3.83% | 7.72 | |
| 28 Feb 2023 | 3.85% | 10.18 | |
| 15 Mar 2023 | 4.22% | 9.37 | |
| 31 Mar 2023 | 4.81% | 10.64 | 10-K filed, results (8-K) |
| 14 Apr 2023 | 5.40% | 19.42 | |
| 28 Apr 2023 | 6.60% | 5.15 | |
| 15 May 2023 | 7.99% | 5.91 | 10-Q filed, results (8-K) |
| 31 May 2023 | 7.57% | 6.80 | |
| 15 Jun 2023 | 7.43% | 8.16 | |
| 30 Jun 2023 | 6.08% | 5.20 | |
| 14 Jul 2023 | 6.04% | 4.77 | |
| 31 Jul 2023 | 6.17% | 8.06 | |
| 15 Aug 2023 | 5.81% | 10.88 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 5.69% | 7.48 | |
| 15 Sep 2023 | 6.47% | 9.28 | |
| 29 Sep 2023 | 7.41% | 14.75 | |
| 13 Oct 2023 | 7.82% | 8.32 | |
| 31 Oct 2023 | 11.19% | 1.00 | |
| 15 Nov 2023 | 14.62% | 4.54 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 7.59% | 2.85 | |
| 15 Dec 2023 | 3.98% | 2.02 | |
| 29 Dec 2023 | 4.09% | 1.00 |
See also: REVIVA PHARMACEUTICALS HOLDINGS, INC.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.